Azitra (AZTR) USPTO patents

Utility

Auxotrophic Strains of Staphylococcus Bacterium

14 Apr 22

The present disclosure provides recombinant Staphylococcus bacterium (e.g.

Travis Michael Whitfill, Ming-De Deng, David Richard Dodds, Alexander Tikhonov

Filed: 14 May 21

Utility

Therapeutic Treatment of Skin Disease with Recombinant Commensal Skin Microorganisms

9 Dec 21

The invention relates to methods for treating or preventing abnormal skin conditions in a human in need thereof, comprising administering a cell culture composition comprising a living culture of bacteria comprising at least one engineered strain that produces a recombinant polypeptide for therapeutic treatment of the abnormal skin condition.

Azim Momin Munivar, Travis Michael Whitfill

Filed: 2 Jun 20

Utility

Auxotrophic Strains of Staphylococcus Bacterium

2 Sep 21

The present disclosure provides recombinant Staphylococcus bacterium (e.g.

Richard Andrews

Filed: 14 May 21

Utility

Auxotrophic strains of

22 Jun 21

The present disclosure provides recombinant Staphylococcus bacterium (e.g.

Travis Michael Whitfill, Ming-De Deng, David Richard Dodds, Alexander Tikhonov

Filed: 4 Jan 19

Utility

Compositions and Methods for Treatment or Prevention of Skin Diseases and Disorders with Lekti

3 Jun 21

The present disclosure provides, inter alia, treating and/or preventing skin diseases and disorders and symptoms thereof, using recombinant LEKTI domains and microbes genetically modified to express one or more LEKTI protein domains encoded by one or more SPINK genes.

Mark N. Sampson

Filed: 4 Nov 20

Utility

Compositions and Methods for Treatment of Cancer with Lekti

3 Jun 21

The present disclosure provides, inter alia, treating and/or preventing cancer and symptoms thereof, using recombinant LEKTI domains and microbes genetically modified to express one or more LEKTI protein domains encoded by one or more SPINK genes.

Mark N. Sampson

Filed: 4 Nov 20

Utility

Methods and Compositions for Treating Skin Disease with Recombinant Microorganisms

29 Apr 21

The present invention provides isolated plasmids, recombinant microorganisms, kits, and methods for the treatment of inflammatory skin disease.

Travis Michael Whitfill

Filed: 5 Oct 20

Utility

Methods and Compositions for Treating Atopic Dermatitis with Recombinant Microorganisms

11 Mar 21

The present disclosure provides isolated plasmids, recombinant microorganisms, kits, and methods for the treatment of skin diseases, in particular atopic dermatitis.

Travis Michael Whitfill

Filed: 3 Apr 20

Utility

Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

6 Jul 20

The invention relates to methods for treating or preventing abnormal skin conditions in a human in need thereof, comprising administering a cell culture composition comprising a living culture of bacteria comprising at least one engineered strain that produces a recombinant polypeptide for therapeutic treatment of the abnormal skin condition.

Azim Momin Munivar, Travis Michael Whitfill

Filed: 27 May 15

Utility

Methods and Compositions for Treating Inflammatory Skin Disease with Recombinant Microorganisms

2 Oct 19

The present invention provides isolated plasmids, recombinant microorganisms, kits, and methods for the treatment of inflammatory skin disease.

Travis Michael Whitfill

Filed: 4 Sep 18